Lianhua Qingxi with overall treatment characteristics

Whether it is a common cold, flu, or repeated new crown pneumonia, from the perspective of Chinese medicine, it is an external fever
.
Most of the initial manifestations of the disease include fever, cough, sore throat, headache, muscle aches and other symptoms
.
The reason why patients have these symptoms is because the evil ingress or the evil ingress invades the lungs
.
For the common cold, flu and new crown pneumonia, even Huaqingxi can show good treatment effect, which is closely related to
the fact that Lianhuaqingxi is a proprietary Chinese medicine, and traditional Chinese medicine has the characteristics of overall treatment.

The composition of the drug has an overall therapeutic character

Lian Hua Qing Plague uses the theory of traditional Chinese medicine network disease to explore the law and treatment of external temperature disease and plague transmission, and proposes to "actively intervene" in viral infectious diseases such as the common cold, influenza, and new crown pneumonia, that is, to let the drug effect exert itself before
the disease progresses.

From the perspective of traditional Chinese medicine, Lianhua Qingxi has the same treatment of health qi and double solution in appearance; Medication with prospects, truncation of the disease; Overall regulation, characteristics of
multi-target therapy.
The drug brings together the essence of the medicine used by physicians of previous generations to treat external temperature diseases and epidemic certificates, and its formula brings together more than 2,000 years of experience in the prevention and treatment of epidemic diseases in traditional Chinese medicine, based on the Eastern Han Dynasty Zhang Zhongjing's "On Typhoid Miscellaneous Diseases" Ma Xingshi Gan Tang and the Qing Dynasty Wu Jutong's "Identification of Warm Diseases" silver warp dispersion, drawing on the experience of rhubarb used in the Ming Dynasty Wu to treat epidemics, and at the same time with Wu Huo aromatic wet protection of the spleen and stomach, Rhodiola Rosea to regulate immunity and strengthen the right qi, and at the same time combined with modern scientific research found in the antiviral, anti-inflammatory, cough, phlegm, enhance immunity of effective Chinese medicine developed
。 The rhubarb in the formula leaks the lungs, and the lungs and the large intestine are on the surface, so that the "epidemic virus" is excreted from the stool, so that the evil has a way out, and another value of using rhubarb is to use drugs in advance to cut off the disease; The use of Huo Xiang aromatizes dampness and avoids turbidity, which can improve the condition of loss of appetite and dampness and spleen and stomach; Rhodiola rosea grows in cold and high altitude areas, has the effect of tonifying the lungs and calming asthma and activating blood, can improve the body's ability to resist fatigue and hypoxia, and has the effect of enhancing immunity, which can improve the body's ability
to resist disease and rehabilitate.

The drug composition of Lianhua Qingxi covers Xin Liang Surface, Lung Relief, Cough and Asthma, Heat Clearing and Detoxification, etc.
, modern pharmacological studies have found that these drug combinations have good antipyretic, cough, anti-inflammatory, antiviral effects
.
That is to say, it does not work like Western medicine is a single function, but has multiple effects, and a study from Tianjin University of Traditional Chinese Medicine also confirmed that Lianhua Qingxi has multiple target characteristics
to exert therapeutic effects.
This study used the database and relevant literature to screen out the active ingredients and targets of Lianhua Qingxi, and after screening, a total of 378 active ingredients of Lianhua Qingxi, 282 potential targets of action, corresponding to 55 2019-nCoV targets were obtained, indicating that the mechanism of action of Lianhua Qingxi in the treatment of new coronary pneumonia may be related to
broad-spectrum antiviral, bacteriostatic and antipyretic, cough and phlegm, and immune regulation.

Experimental studies have overall antiviral, anti-inflammatory, cough and expectorant effects

Since the listing of Lianhua Qingxi in 2005, many domestic institutions have done a lot of experimental research and clinical research
around the drug.
The results of the study showed that Lianhua Qingxi can be broad-spectrum antiviral
.

Studies by the Chinese Academy of Chinese Medical Sciences and other scientific research institutes have found that Lianhua Qingxi has inhibitory effects on respiratory syncytial virus, parainfluenza virus, rhinovirus, adenovirus, etc.
, and these viruses are mostly viruses
that cause the common cold.
For influenza viruses, basic research by Guangzhou Institute of Respiratory Diseases, Chinese Academy of Chinese Medical Sciences and other scientific research institutes has confirmed that Lianhua Qingxi can significantly inhibit a variety of influenza viruses such as influenza A H1N1, H3N2, avian influenza H5N1, H9N2, H7N9 and influenza B virus, among which the inhibitory effect on influenza A H3N2 virus is the strongest
.
For the new coronavirus circulating in the past two years, the State Key Laboratory found that Lianhua Qingxi has a good inhibitory effect
on cytopathies caused by common coronavirus (HCoV-229E) and novel coronavirus (COVID-19) infection.
In addition, Lianhua Qingxi showed inhibitory effects
on the expression of TNF-α, IL-6, CCL2/MCP-1 and CXCL-10/IP-10 inflammatory factors caused by HCoV-229E and COVID-19-infected cells.
Lianhua Qingxi shows antiviral and anti-inflammatory effects
against the new coronavirus at the cellular level.

Lianhua Qingxi can effectively inhibit a variety of bacteria, has a good antibacterial and anti-inflammatory effect, and is conducive to the treatment of mixed infections
.
Through a number of studies by many domestic scientific research institutes, Lianhua Qingxi has inhibitory effect on Staphylococcus aureus, alpha B hemolytic streptococcus, pneumococcus, influenza bacillus, etc.
, which can prevent secondary bacterial infection of colds and influenza, and can effectively prevent the occurrence
of complications such as bronchitis, pneumonia, tonsillitis, etc.
What's more valuable is that the researchers also found that Lianhua Qingxi can kill bacteria in bacterial biofilms, and can significantly inhibit the number of viable bacteria in biofilms, bringing light to cracking bacterial drug resistance
.

Lianhua Qingxi capsules have significant cough and phlegm effect, and it has been confirmed by experiments that Lianhua Qingxi capsules can promote the excretion of tracheal phenol red, prolong the cough incubation period and cough frequency of ammonia and citric acid in mice and guinea pigs, and have significant cough and phlegm dissolving effects
.
Clinical evidence-based medical studies involving 13 tertiary hospitals across the country have shown that Lianhua Qingxi has shown good efficacy
in improving clinical symptoms such as fever, cough, phlegm, chest pain, muscle aches, and dyspnea in patients with viral pneumonia.

Although a large number of studies have found that Lianhua Qingxi can be anti-inflammatory and anti-viral, the fundamental role it plays is the overall therapeutic effect of the body, and multi-target plays a role
.
The antiviral concept of Chinese medicine is different from Western medicine, and Chinese medicine has a systemic regulating effect, which is the characteristic and advantage of Chinese medicine
.
Lianhua Qingxi is aimed at fever, cough, phlegm sticky can not be coughed out, sore throat, fatigue, muscle aches and other symptoms of external fever, common cold, flu, new crown pneumonia can manifest such a syndrome, the mechanism of action of Lianhua Qingxi lies in the overall regulation, multi-target synergy to play anti-inflammatory, anti-viral, cough and asthma, enhance the body's immune effect
.
As long as the symptoms are the same, whether it is new crown pneumonia, common cold, flu, you can use Lianhua Qingxi for treatment
.